Synchron

Synchron has developed a minimally invasive implantable BCI system called “Stentrode.” The Stentrode is a small device that is implanted into the blood vessels in the brain and allows patients to control assistive technologies using their thoughts. The Stentrode was initially tested on four people in Australia that had ALS and severe paralysis, it successfully allowed them to use the device to carry out online activities like shopping and sending emails. Since then, Synchron began the industry-first FDA-approved clinical trial for the Stentrode in the U.S.

Synchron has also developed the Synchron Switch, a non-invasive wearable BCI system that is worn on the head like a cap. It uses electroencephalography (EEG) technology to measure electrical activity in the brain and interpret the signals to control assistive technologies. A study involving 10 people was conducted in Australia. The participants were able to control an on-screen cursor and a prosthetic arm using their brain signals.